Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $20,646 | 1,267 | 99.4% |
| Education | $130.10 | 14 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,788 | 141 | $0 (2024) |
| Novo Nordisk Inc | $2,418 | 148 | $0 (2024) |
| ABBVIE INC. | $2,220 | 143 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,469 | 106 | $0 (2024) |
| PFIZER INC. | $1,409 | 112 | $0 (2024) |
| Lilly USA, LLC | $1,159 | 87 | $0 (2024) |
| Amgen Inc. | $1,147 | 68 | $0 (2024) |
| Abbott Laboratories | $707.11 | 40 | $0 (2024) |
| Amarin Pharma Inc. | $652.88 | 43 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $615.67 | 31 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,481 | 187 | AstraZeneca Pharmaceuticals LP ($636.53) |
| 2023 | $3,816 | 216 | ABBVIE INC. ($633.82) |
| 2022 | $2,866 | 172 | ABBVIE INC. ($557.60) |
| 2021 | $2,998 | 187 | Novo Nordisk Inc ($696.69) |
| 2020 | $2,246 | 148 | Amarin Pharma Inc. ($319.97) |
| 2019 | $2,405 | 174 | AstraZeneca Pharmaceuticals LP ($474.10) |
| 2018 | $2,450 | 161 | AstraZeneca Pharmaceuticals LP ($568.25) |
| 2017 | $512.35 | 36 | AstraZeneca Pharmaceuticals LP ($85.93) |
All Payment Transactions
1,281 individual payment records from CMS Open Payments — Page 1 of 52
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: Diabetes Care | ||||||
| 12/19/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 12/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: Diabetes | ||||||
| 12/17/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $26.12 | General |
| Category: Neuroscience | ||||||
| 12/12/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: DERMATOLOGY | ||||||
| 12/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: Respiratory | ||||||
| 12/04/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/04/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $1.79 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/03/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: PAIN | ||||||
| 12/02/2024 | Lucid Diagnostics Inc. | — | Food and Beverage | In-kind items and services | $23.02 | General |
| 11/22/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $2.44 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: Diabetes Care | ||||||
| 11/19/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $8.95 | General |
| Category: PAIN | ||||||
| 11/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: RESPIRATORY | ||||||
| 11/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $0.44 | General |
| Category: RESPIRATORY | ||||||
| 11/13/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: Inflammation | ||||||
| 11/08/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.95 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $29.65 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/06/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: PAIN | ||||||
| 11/06/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: Diabetes Care | ||||||
| 11/05/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 501 | 705 | $191,870 | $55,013 |
| 2022 | 13 | 528 | 953 | $202,082 | $59,470 |
| 2021 | 11 | 501 | 892 | $191,269 | $57,235 |
| 2020 | 17 | 642 | 1,066 | $226,606 | $55,273 |
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 165 | 319 | $108,543 | $27,281 | 25.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 110 | 110 | $39,326 | $13,830 | 35.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 76 | 100 | $23,617 | $6,305 | 26.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 13 | 13 | $9,347 | $3,668 | 39.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 26 | 26 | $3,354 | $1,870 | 55.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 29 | 29 | $2,204 | $876.96 | 39.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 24 | 41 | $2,810 | $425.10 | 15.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 14 | 14 | $1,064 | $423.36 | 39.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 13 | 15 | $534.00 | $142.80 | 26.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 13 | 13 | $845.00 | $135.36 | 16.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 18 | 25 | $226.00 | $55.00 | 24.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 159 | 372 | $120,528 | $32,315 | 26.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 107 | 107 | $37,343 | $13,783 | 36.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 54 | 65 | $14,300 | $3,857 | 27.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 11 | 11 | $7,909 | $3,070 | 38.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 41 | 41 | $5,289 | $2,804 | 53.0% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 16 | 32 | $7,548 | $1,329 | 17.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 45 | 45 | $3,420 | $1,291 | 37.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 24 | 32 | $2,432 | $334.95 | 13.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 11 | 11 | $836.00 | $316.46 | 37.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 18 | 20 | $1,287 | $204.37 | 15.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 15 | 140 | $840.00 | $108.71 | 12.9% |
| 81003 | Automated urinalysis test | Office | 2022 | 16 | 17 | $170.00 | $37.49 | 22.1% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2022 | 11 | 60 | $180.00 | $18.98 | 10.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 181 | 388 | $125,712 | $35,343 | 28.1% |
About Dr. Ray Lebeda, M.D
Dr. Ray Lebeda, M.D is a Family Medicine healthcare provider based in Lake Mary, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1619933397.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ray Lebeda, M.D has received a total of $20,776 in payments from pharmaceutical and medical device companies, with $3,481 received in 2024. These payments were reported across 1,281 transactions from 61 companies. The most common payment nature is "Food and Beverage" ($20,646).
As a Medicare-enrolled provider, Lebeda has provided services to 2,172 Medicare beneficiaries, totaling 3,616 services with total Medicare billing of $226,990. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Lake Mary, FL
- Active Since 04/21/2006
- Last Updated 05/26/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1619933397
Products in Payments
- FARXIGA (Drug) $1,594
- Ozempic (Drug) $1,212
- JARDIANCE (Drug) $1,027
- NURTEC ODT (Drug) $907.08
- VRAYLAR (Drug) $774.22
- UBRELVY (Drug) $749.25
- QULIPTA (Drug) $680.80
- Vascepa (Drug) $652.88
- Rybelsus (Drug) $608.44
- Kerendia (Drug) $560.03
- XIFAXAN (Drug) $544.21
- BREZTRI (Drug) $529.07
- FREESTYLE LIBRE 3 (Device) $493.57
- ELIQUIS (Drug) $407.77
- TRULICITY (Drug) $399.04
- Cologuard Collection Kit (Device) $396.76
- SYMBICORT (Drug) $369.98
- JANUVIA (Drug) $366.60
- XARELTO (Drug) $352.83
- CHANTIX (Drug) $343.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Lake Mary
Dr. Christopher Caggiano, D.o, D.O
Family Medicine — Payments: $30,422
Carlos Mercado, M.d, M.D
Family Medicine — Payments: $15,022
Dr. Michael Bougoulias, M.d, M.D
Family Medicine — Payments: $11,692
Ayesha Ahmar, Md, MD
Family Medicine — Payments: $7,239
Candace Kuzma, Do, DO
Family Medicine — Payments: $4,661
Dr. Vina Gohill, M.d, M.D
Family Medicine — Payments: $3,346